Position in PFE
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$699,331
-$133,577 QoQ
Shares Held
29,042
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,532
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BURNS J W & CO INC/NY holds $40,501,690 across 10 Drug Manufacturers - General names. PFE ranks #8 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
53,495 | $13,586,125 | |
| 2 | ABBV |
AbbVie Inc.
|
36,406 | $9,161,205 | |
| 3 | AMGN |
Amgen Inc
|
22,691 | $8,216,864 | |
| 4 | LLY |
ELI LILLY & Co
|
4,335 | $5,199,529 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,774 | $1,542,717 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,012 | $901,042 | |
| 7 | NVS |
Novartis AG
|
4,915 | $770,278 | |
| 8 | PFE |
Pfizer Inc
This page
|
29,042 | $699,331 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $699,331 | 29,042 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $832,908 | 29,662 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $738,583 | 29,662 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $748,143 | 29,362 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $731,829 | 30,191 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $836,954 | 33,029 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $948,182 | 35,740 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,267,398 | 43,794 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $1,361,338 | 48,654 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $1,509,738 | 54,405 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $2,002,603 | 69,559 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $2,578,867 | 77,747 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,077,965 | 83,914 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $3,616,756 | 88,646 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $4,643,625 | 90,625 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $4,026,663 | 92,017 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $4,832,787 | 92,176 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $4,815,748 | 93,022 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $5,852,209 | 99,106 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $4,218,420 | 98,080 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $4,017,737 | 102,598 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $3,665,860 | 101,183 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $3,655,637 | 99,311 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $3,405,646 | 92,797 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $2,845,949 | 87,032 | Shares | Sole | 2020-07-06 | |
| 2020-03-31 | $2,746,619 | 84,149 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||